share_log

HC Wainwright & Co. Reiterates Buy on PMV Pharma, Maintains $5 Price Target

Benzinga ·  Mar 20 10:33

HC Wainwright & Co. analyst Robert Burns reiterates PMV Pharma (NASDAQ:PMVP) with a Buy and maintains $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 255

Recommended

Write a comment